Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov 5;215(1-2):90-6.
doi: 10.1016/j.tox.2005.06.026. Epub 2005 Aug 19.

Multi-organic risk assessment of estrogenic properties of octyl-methoxycinnamate in vivo A 5-day sub-acute pharmacodynamic study with ovariectomized rats

Holger Klammer  1 , Christiane Schlecht, Wolfgang Wuttke, Hubertus Jarry
Affiliations

Multi-organic risk assessment of estrogenic properties of octyl-methoxycinnamate in vivo A 5-day sub-acute pharmacodynamic study with ovariectomized rats

Holger Klammer et al. Toxicology. .

Abstract

Sun protection products contain a variety of UV-filters, among others, octyl-methoxycinnamate (OMC). Recently, an uterotrophic effect in immature rats has been reported, indicating that OMC might have estrogenic properties and thus is an endocrine active chemical (EAC). However, determination of an estrogenic activity in the uterus only is a restricted approach with the potential risk of missing undesirable actions in other organs regulated by estrogens. A pharmacodynamic experiment with 5 dosages of OMC in adult ovariectomized (ovx) rats was carried out to quantify the multi-organic estrogenic properties of OMC. As control compound, estradiol-valerate (E2) was included. Animals were treated per gavage for 5 days. The expression levels of markers of estrogenic action in several organs were measured by RT-PCR. Effects on metabolic parameters were assessed by determination of the serum concentrations of leptin, cholesterol, high and low density lipoproteins (HDL and LDL), glucose and triglycerides. Observed changes upon OMC treatment were analyzed using the NO(A)EL and the benchmark dose approach. From the obtained pharmacodynamic data of the most sensitive parameter (truncated estrogen receptor protein 1 gene expression in the pituitary) we obtained threshold values that are exceeded by the recommended use of OMC containing formulations for skin protection in humans, therefore we propose to reduce the use of OMC in cosmetic products. In addition to estrogenic actions of OMC, non-estrogenic effects have been found for this chemical supporting the need of a multi-organic risk assessment of putative EACs.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources